5 FDA actions
TREMFYA (GUSELKUMAB)
JANSSEN BIOTECH
USTEKINUMAB
RYBREVANT FASPRO
DARZALEX FASPRO (DARATUMUMAB AND HYALURONIDASE-FIHJ (HUMAN RECOMBINANT))
SIMPONI ARIA (GOLIMUMAB)